FIELD: pharmaceuticals.
SUBSTANCE: invention relates to an intranasal pharmaceutical composition for correcting cerebrovascular disorders. Intranasal pharmaceutical composition for correcting cerebrovascular disorders is characterised by containing spissum extract of ginkgo biloba as an active component and glycerin, ascorbic acid, nipagin, nipasol, chitosan and purified water as target additives, with a certain ratio of ingredients.
EFFECT: above composition is characterised by high stability and bioavailability.
1 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING AGENT POSSESSING ANTI-ISCHEMIC AND ANTIOXIDANT ACTIVITY | 2015 |
|
RU2603465C1 |
COMBINED REMEDY FOR IMPROVING THE FUNCTIONAL STATE OF THE BRAIN | 2021 |
|
RU2782672C1 |
CHINESE DRUG COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES OR DEMENTIA AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2674264C1 |
ESTER-OIL COMPOSITION 'BIOPROTECTION' FOR TREATING ASTHENIC SYNDROME IN PATIENTS WITH DYSCIRCULATORY ENCEPHALOPATHY | 2013 |
|
RU2553625C2 |
METHOD FOR PREVENTING CEREBRAL ISCHEMIA | 2018 |
|
RU2696203C1 |
MEANS STIMULATING REPARATION OF TISSUES WITH THERMAL BURNS | 2018 |
|
RU2681850C1 |
MEDICINAL AGENT FOR PREVENTING AND TREATING CEREBRAL DISEASES AND METHOD OF TREATING CEREBRAL DISEASES | 2015 |
|
RU2692063C2 |
METHOD FOR PRODUCING A DRY EXTRACT FROM GINKGO BILOBA LEAVES | 2021 |
|
RU2767255C1 |
METHOD FOR PREVENTION OF BRAIN ISCHEMIA | 2017 |
|
RU2642961C1 |
NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT COMPONENTS AND USES THEREOF | 2008 |
|
RU2519718C2 |
Authors
Dates
2023-01-12—Published
2022-04-07—Filed